ABOUT THIS EPISODE
We talk with Alan Gourdie and Spencer Marsh from The Tiny Cargo Company, the team commercializing one of nature’s most elegant delivery systems, milk-derived exosomes.
We dig into what makes milk exosomes uniquely suited for oral delivery of peptides and GLP-1’s, and beyond. From biologics and monoclonal antibodies to skincare actives and nutraceuticals, the implications reach across human health.
Spencer and Alan break down the biology, the scalability, and the data behind their platform; high loading efficiency, barrier penetration, long-term stability, and natural biocompatibility, and what it takes to turn a naturally evolved system into an industrial-scale solution for pharma and consumer health.
A conversation about precision delivery, sustainability, and how sometimes the most advanced technology has been in nature all along.
